Recommendation paper on decentralised elements in clinical trials
The intention of the recommendation paper is to facilitate the use of decentralised elements in clinical trials in the EU/EEA. However, the necessary level of trial participant’s safety, protection of their rights and dignity should be ensured, and the reliability of data for publication and submission for regulatory decision-making should be guaranteed.
Read the news announcement published by EC Directorate-General for Health and Food Safety on 14 December 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (24 janvier 2023). Recommendation paper on decentralised elements in clinical trials. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/o666





